Eating DisordersNCT06306586
A Digital Treatment for Adolescents With Eating Disorders
A study testing Digital Treatment for Adolescents With Eating Disorders in people with Eating Disorders, run by Haukeland University Hospital at 3 sites in Norway.
Trial summary
The goal of this feasibility study is to evaluate the feasibility and preliminary clinical outcomes of a personalized digital treatment for adolescents with eating disorders. The main objectives are to: i) Evaluate whether a personalized digital treatment for adolescents with eating disorders are feasible in a child… Read more about this study
- Who is it for?
- Ages 15 to 18 years
- Conditions the study is for
- Eating Disorders
- What is being tested?
- Digital Treatment for Adolescents With Eating Disorders
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 3 sitesNorway
- Study dates
- 11 Mar 2024to 1 Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Diagnosed with F50.1 Atypical anorexia nervosa, F50.3 Atypical bulimia nervosa, F50.8 Other eating disorders, F50.9 Eating disorder, unspecified
- Age between 15 and 18 years.
- Stable dose of medication for a co-morbid psychiatric treatment for six weeks and who continue to meet study entry criteria.
- Internet access.
- Speaks and write Norwegian.
Who cannot join
- Diagnosed with F50.0 Anorexia nervosa or F50.2 Bulimia nervosa
- Disorders of psychological development (F80-F89).
- Patients with avoidant restrictive food intake disorders (F50.82)
- Participants with a co-morbid medical condition or disorder known to influence eating or weight (i.e., pregnancy, cancer), psychotic disorders, acute suicidality, or substance abuse and/or substance dependence and severe depressive episode.
- Receiving inpatient- or face to face psychological treatment.
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Norway3 sites, 1 recruiting
- Recruiting
Haukeland University Hospital
Bergen
- Withdrawn
Bømlo Kommune
Bømlo, Vestland
- Completed
Helse Fonna
Haugesund
About this study
Official title: Evaluation of a Personalised Digital Treatment for Adolescents With Eating Disorders - An Open Feasibility Trial in Routine Care
The goal of this feasibility study is to evaluate the feasibility and preliminary clinical outcomes of a personalized digital treatment for adolescents with eating disorders. The main objectives are to:
- Evaluate whether a personalized digital treatment for adolescents with eating disorders are feasible in a child and adolescent psychiatric outpatient clinic. ii) Evaluate who benefits from a personalized digital treatment for adolescents with eating disorders (what works for whom?) iii) Evaluate the cost-benefit of a personalized digital treatment for adolescents with eating disorders.
Participants will be enrolled in a 10-week digital treatment including weekly therapist contact. They will be asked to complete self-report questionnaires at pre-, during, post- and 3- and 6-months follow-up.
Read the detailed description
Eating disorders are associated with high levels of distress, significant somatic problems, and high mortality. The difficulties have significant consequences for the individual, family members, and society at large. Early treatment leads to better prognosis, but the identification and treatment of eating disorders are challenging within the healthcare system. The effect of digital treatments for patients with eating disorders appears promising.
In this study, we will investigate the feasibility and preliminary effects of therapist-guided digital treatment for youth with eating disorders using qualitative and quantitative methods. The project uses the Person-based approach (PBA) as methodological framework, which is an evidence-based method for developing user-centered and effective behavior change interventions.
The study wants the examine the intervention within six feasibility domains that includes the following research questions:
Feasibility domain 1. Sample distribution of general psychopathology of eating disorder symptoms:
- Will a reasonable wide spectrum of individuals with different forms of eating disorders show interest and be eligible? B. Will 60 adolescents be eligible over the course of one year? C. What characterizes the group that participate (predictor)?
Feasibility domain 2. Adherence to the treatment protocol:
- Do 50% of the adolescents complete the entire intervention? B, What characterizes those who carry out the treatment (predictor)? C. What characterizes those who drop out (predictor)?
Feasibility domain 3. Treatment credibility:
- Will 70% of the participants rate the treatment as acceptable/recommend it to a friend?
Feasibility domain 4. Treatment acceptability:
- What are the adolescents' experiences of a personalised digital treatment targeting eating disorders?
Feasibility domain 5. Treatment use and utility:
- Will a moderate within-group effect, around d=0.50, be seen on general psychopathology of eating disorder? B. Will more than 40% of the sample obtain a significant reliable change on primary outcome? C. Will less than 10% of the sample experience negative effects and/or deterioration defined as a negative significant reliable change?
Feasibility domain 6. Treatment cost-effectiveness:
- What is the cost-effectiveness of a personalized digital treatment for for adolescents with eating disorders in routine care?
Youth between the ages of 16-18 with an eating disorder will be invited to participate in this intervention study. The participants will be recruited via child and youth psychiatric outpatient clinics and social and media. Eligible participants get access to an online information consent form which is signed digitally using the Norwegian electronic identification system BankID.
Data will be collected using self-report questionnaires administrated online at pre-, during, post- and 3- and 6-months follow-up. All measures are previously validated and have been used in eating disorder adolescent populations. Based on the literature potential predictors are included in the study protocol. The pre-treatment symptoms variables are associated with external clinical features, which maintain an eating disorder. The predictor variables will be collected pre-treatment.
We will conduct semi-structured phone interviews to explore the patients' in-depth experience of the digital treatment. The interviews of approximately 16 adolescents will be conducted 2-4 weeks after finishing the treatment. We will strive to have two groups, one with participants that finished the treatment, and one with dropouts.
- Conditions
- Eating Disorders
- Being tested
- Digital Treatment for Adolescents With Eating Disorders
- Keywords
- Digital interventions, eating disorders, adolescents
- Medical subject headings
- Feeding and Eating Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Digital Treatment for Adolescents With Eating DisordersBehavioural
Also called e-balanse
The main aim of the digital treatment is to reduce symptoms of eating disorders and increase life-coping skills. The digital treatment aims to help adolescents with eating disorders to:
- Gain knowledge about the symptoms of eating disorders and the consequences it has on everyday life.
- Be motivated to carry out the treatment.
- Gain knowledge of and skills in regulating food and activity in a more balanced way.
- Gain knowledge of and skills in managing emotions.
- Get tools to develop a better self-esteem.
- Gain awareness of the function of the eating disorder.
- Gain skills in coping with social challenges.
- Get a more realistic image of their bodies and handle information from social media.
| Study group | Role | What they receive |
|---|---|---|
| Digital Treatment for Adolescents With Eating Disorders | Experimental | The digital treatment is guided by a therapist and comprises 8 modules, running over a span of 10 weeks. Receives: Behavioral: Digital Treatment for Adolescents With Eating Disorders |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Credibility and Expectancy Scale (CEQ-1)
CEQ-1 will be used after participants have completed the first module of the treatment. CEQ measures perceived treatments credibility. We will use 1-item "How confident would you be in recommending this treatment to a friend who experiences similar problems?" The item is rated on a scale from 0 to 10, where higher score indicates better treatment credibility.
Measured: One week
Adherence
Adherence (dropout rates and completion of modules) will be used to assess the acceptability of the intervention. The total number of logged on sessions during the intervention period will be collected, and the average length of sessions. Days in treatment will be calculated based on the dates between the first login, and the completion of the last module.
Measured: Up to 10 weeks
Module evaluations
After each treatment module the participants will be asked to evaluate the module which will be used to assess acceptability of the intervention. With a 6-item self-report questionnaire assessed on a 5-point Likert scale ranging from "completely disagree" to "completely agree".
Measured: Up to 10 weeks
Client Satisfaction Questionnaire (CSQ-3)
Intervention satisfaction will be measured at post-treatment, using the 3-item Client Satisfaction Questionnaire (CSQ-3) CSQ-3 are items 3, 7, \& 8 from the CSQ-8. Each item on the CSQ-3 is scored from 1 to 4, where a higher score indicate higher satisfaction.
Measured: 10 weeks
Recruitment
Number of participants of participants recruited and inclusion rate will be used to assess the acceptability.
Measured: 1 year
Eating disorder symptoms
Eating Disorder Examination-Questionnaire Short (EDE-QS) is a 12 item self-report questionnaire that with a 4-point response scale assess eating disorder symptom severity over the preceding 7 days. It has demonstrated good psychometric properties at initial testing.
Measured: Up to 6-months follow-up
The Clinical Impairment Assessment Questionnaire (CIA)
We will use the The Clinical Impairment Assessment Questionnaire (CIA) to assess quality of life. CIA assess the severity of psychosocial impairment due to eating disorder features. It is a 16-item self-report questionnaire that cover impairment in domains of life that are typically affected by eating disorder psychopathology: mode and self-perception, cognitive functioning, interpersonal functioning, and work performance.
Measured: Up to 6-months follow-up
The KIDSCREEN (KIDSCREEN-10)
The KIDSCREEN (KIDSCREEN-10) will be used to assess quality of life. The items are rated on 5-point Likert scale that indicates the frequency or intensity of a behavior or emotion.
Measured: Up to 6 months follow-up
Secondary outcomes (6)
The Patient Health Questionnaire (PHQ-2)
The Patient Health Questionnaire (PHQ-2) are used for assessing depression. The PHQ-2, comprising the first 2 items of the PHQ-9, inquiries about the degree to which an individual has experienced depressed mood and anhedonia over the past two weeks. Items are rated on scale from 1 to 4, where a higher rating indicate higher degree of depressed mood.
Measured: Up to 6-months follow-up
Generalized Anxiety Disorder scale (GAD-2)
Generalized Anxiety Disorder scale (GAD-2) is used for assessing anxiety disorders. The GAD-2 is a quick version of the seven-item scale that incorporates the first two questions of the GAD-7, which are also critical components of any anxiety disorder.Items are rated on scale from 1 to 4, where a higher rating indicate higher degree of anxiety.
Measured: Up to 6-months follow-up
School attendance
In addition, we will collect School attendance (variables: full-time/reduce-time/don't attend school/ don't attend school but have a job) to assess quality of life.
Measured: Up to 6-months follow-up
Tme with friends
Time with friends with the categories: daily/weekly/monthly/don't have friends/ don't have time to friends because of my eating disorder, will also be used to assess quality of life.
Measured: Up to 6-months follow-up
Difficulties with Emotion Regulation Scale (DERS-18)
Difficulties with Emotion Regulation Scale (DERS-18) are used to assess used to facilitate understanding of how emotion dysregulation is associated with psychiatric symptoms, other emotion-related constructs, and treatment progress. Responses are rated one a scale from 1 to 5, ranging from never to almost always, where a higher score indicates higher severity.
Measured: Up to 6-months follow-up
EuroQoL 5D-5L (EQ-5D-5L)
EuroQoL 5D-5L (EQ-5D-5L) measures health-related quality of life and provide data for calculation of Quality Adjusted Life Years (QALY), to be used in the economic evaluation. The questionnaire covers five dimensions of health (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), identify the health states and together with preference scores provides a single index score in order to calculate QALYs.
Measured: Up to 6-months follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2024
- Study start11 Mar 2024
- Primary completion1 Jan 2027 (estimated)
- Study completion1 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Eating DisordersStudies of the same condition, open and under way.
- More trials run by Haukeland University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Haukeland University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Helse Fonna
- Responsible party
- Sponsor
- Investigators
- Tine Nordgreen, PhD, Principal investigator, Division of Psychiatry, Haukeland University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06306586
- Sponsor's protocol ID
- 639031
- Status last verified
- Mar 2025
- First submitted
- 28 Feb 2024
- Last updated
- 22 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Holgersen G, Nordby ES, Espeset EMS, Nordgreen T. The acceptability, adherence, and preliminary effectiveness of a digital treatment for adolescents with subthreshold eating disorders. Findings from an open feasibility trial in routine clinical care. J Eat Disord. 2026 Apr 9;14(1):115. doi: 10.1186/s40337-026-01596-9.
PubMed 41957670
Study at a glance
From the registry record, last updated by the sponsor on 22 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of a Personalised Digital Treatment for Adolescents With Eating Disorders - An Open Feasibility Trial in Routine Care
- ClinicalTrials.gov ID
- NCT06306586
- Acronym / sponsor ID
- 639031
- Conditions
- Eating Disorders
- Keywords
- Digital interventions, eating disorders, adolescents
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Haukeland University HospitalUniversity, hospital or other
- Collaborators
- Helse Fonna
- Study start
- 11 Mar 2024 (actual)
- Primary completion
- 1 Jan 2027 (estimated)
- Study completion
- 1 Jan 2027 (estimated)
- First posted
- 12 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this feasibility study is to evaluate the feasibility and preliminary clinical outcomes of a personalized digital treatment for adolescents with eating disorders. The main objectives are to:
- Evaluate whether a personalized digital treatment for adolescents with eating disorders are feasible in a child and adolescent psychiatric outpatient clinic. ii) Evaluate who benefits from a personalized digital treatment for adolescents with eating disorders (what works for whom?) iii) Evaluate the cost-benefit of a personalized digital treatment for adolescents with eating disorders.
Participants will be enrolled in a 10-week digital treatment including weekly therapist contact. They will be asked to complete self-report questionnaires at pre-, during, post- and 3- and 6-months follow-up.
Detailed description
Eating disorders are associated with high levels of distress, significant somatic problems, and high mortality. The difficulties have significant consequences for the individual, family members, and society at large. Early treatment leads to better prognosis, but the identification and treatment of eating disorders are challenging within the healthcare system. The effect of digital treatments for patients with eating disorders appears promising.
In this study, we will investigate the feasibility and preliminary effects of therapist-guided digital treatment for youth with eating disorders using qualitative and quantitative methods. The project uses the Person-based approach (PBA) as methodological framework, which is an evidence-based method for developing user-centered and effective behavior change interventions.
The study wants the examine the intervention within six feasibility domains that includes the following research questions:
Feasibility domain 1. Sample distribution of general psychopathology of eating disorder symptoms:
- Will a reasonable wide spectrum of individuals with different forms of eating disorders show interest and be eligible? B. Will 60 adolescents be eligible over the course of one year? C. What characterizes the group that participate (predictor)?
Feasibility domain 2. Adherence to the treatment protocol:
- Do 50% of the adolescents complete the entire intervention? B, What characterizes those who carry out the treatment (predictor)? C. What characterizes those who drop out (predictor)?
Feasibility domain 3. Treatment credibility:
- Will 70% of the participants rate the treatment as acceptable/recommend it to a friend?
Feasibility domain 4. Treatment acceptability:
- What are the adolescents' experiences of a personalised digital treatment targeting eating disorders?
Feasibility domain 5. Treatment use and utility:
- Will a moderate within-group effect, around d=0.50, be seen on general psychopathology of eating disorder? B. Will more than 40% of the sample obtain a significant reliable change on primary outcome? C. Will less than 10% of the sample experience negative effects and/or deterioration defined as a negative significant reliable change?
Feasibility domain 6. Treatment cost-effectiveness:
- What is the cost-effectiveness of a personalized digital treatment for for adolescents with eating disorders in routine care?
Youth between the ages of 16-18 with an eating disorder will be invited to participate in this intervention study. The participants will be recruited via child and youth psychiatric outpatient clinics and social and media. Eligible participants get access to an online information consent form which is signed digitally using the Norwegian electronic identification system BankID.
Data will be collected using self-report questionnaires administrated online at pre-, during, post- and 3- and 6-months follow-up. All measures are previously validated and have been used in eating disorder adolescent populations. Based on the literature potential predictors are included in the study protocol. The pre-treatment symptoms variables are associated with external clinical features, which maintain an eating disorder. The predictor variables will be collected pre-treatment.
We will conduct semi-structured phone interviews to explore the patients' in-depth experience of the digital treatment. The interviews of approximately 16 adolescents will be conducted 2-4 weeks after finishing the treatment. We will strive to have two groups, one with participants that finished the treatment, and one with dropouts.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Digital Treatment for Adolescents With Eating Disorders | Experimental | Behavioral: Digital Treatment for Adolescents With Eating DisordersThe digital treatment is guided by a therapist and comprises 8 modules, running over a span of 10 weeks. |
Who may qualify
- Ages
- 15 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (5 listed)
- Diagnosed with F50.1 Atypical anorexia nervosa, F50.3 Atypical bulimia nervosa, F50.8 Other eating disorders, F50.9 Eating disorder, unspecified
- Age between 15 and 18 years.
- Stable dose of medication for a co-morbid psychiatric treatment for six weeks and who continue to meet study entry criteria.
- Internet access.
- Speaks and write Norwegian.
Key exclusion criteria (5 listed)
- Diagnosed with F50.0 Anorexia nervosa or F50.2 Bulimia nervosa
- Disorders of psychological development (F80-F89).
- Patients with avoidant restrictive food intake disorders (F50.82)
- Participants with a co-morbid medical condition or disorder known to influence eating or weight (i.e., pregnancy, cancer), psychotic disorders, acute suicidality, or substance abuse and/or substance dependence and severe depressive episode.
- Receiving inpatient- or face to face psychological treatment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Digital Treatment for Adolescents With Eating DisordersAlso: e-balanseThe main aim of the digital treatment is to reduce symptoms of eating disorders and increase life-coping skills. The digital treatment aims to help adolescents with eating disorders to: * Gain knowledge about the symptoms of eating disorders and the consequences it has on everyday life. * Be motivated to carry out the treatment. * Gain knowledge of and skills in regulating food and activity in a more balanced way. * Gain knowledge of and skills in managing emotions. * Get tools to develop a better self-esteem. * Gain awareness of the function of the eating disorder. * Gain skills in coping with social challenges. * Get a more realistic image of their bodies and handle information from social media. | Behavioural | Digital Treatment for Adolescents With Eating Disorders |
Primary outcome
The Credibility and Expectancy Scale (CEQ-1)
Time frame: One week
CEQ-1 will be used after participants have completed the first module of the treatment. CEQ measures perceived treatments credibility. We will use 1-item "How confident would you be in recommending this treatment to a friend who experiences similar problems?" The item is rated on a scale from 0 to 10, where higher score indicates better treatment credibility.
Adherence
Time frame: Up to 10 weeks
Adherence (dropout rates and completion of modules) will be used to assess the acceptability of the intervention. The total number of logged on sessions during the intervention period will be collected, and the average length of sessions. Days in treatment will be calculated based on the dates between the first login, and the completion of the last module.
Module evaluations
Time frame: Up to 10 weeks
After each treatment module the participants will be asked to evaluate the module which will be used to assess acceptability of the intervention. With a 6-item self-report questionnaire assessed on a 5-point Likert scale ranging from "completely disagree" to "completely agree".
Client Satisfaction Questionnaire (CSQ-3)
Time frame: 10 weeks
Intervention satisfaction will be measured at post-treatment, using the 3-item Client Satisfaction Questionnaire (CSQ-3) CSQ-3 are items 3, 7, \& 8 from the CSQ-8. Each item on the CSQ-3 is scored from 1 to 4, where a higher score indicate higher satisfaction.
Recruitment
Time frame: 1 year
Number of participants of participants recruited and inclusion rate will be used to assess the acceptability.
Eating disorder symptoms
Time frame: Up to 6-months follow-up
Eating Disorder Examination-Questionnaire Short (EDE-QS) is a 12 item self-report questionnaire that with a 4-point response scale assess eating disorder symptom severity over the preceding 7 days. It has demonstrated good psychometric properties at initial testing.
The Clinical Impairment Assessment Questionnaire (CIA)
Time frame: Up to 6-months follow-up
We will use the The Clinical Impairment Assessment Questionnaire (CIA) to assess quality of life. CIA assess the severity of psychosocial impairment due to eating disorder features. It is a 16-item self-report questionnaire that cover impairment in domains of life that are typically affected by eating disorder psychopathology: mode and self-perception, cognitive functioning, interpersonal functioning, and work performance.
The KIDSCREEN (KIDSCREEN-10)
Time frame: Up to 6 months follow-up
The KIDSCREEN (KIDSCREEN-10) will be used to assess quality of life. The items are rated on 5-point Likert scale that indicates the frequency or intensity of a behavior or emotion.
6 secondary outcomes
The Patient Health Questionnaire (PHQ-2)
Time frame: Up to 6-months follow-up
Generalized Anxiety Disorder scale (GAD-2)
Time frame: Up to 6-months follow-up
School attendance
Time frame: Up to 6-months follow-up
Tme with friends
Time frame: Up to 6-months follow-up
Difficulties with Emotion Regulation Scale (DERS-18)
Time frame: Up to 6-months follow-up
EuroQoL 5D-5L (EQ-5D-5L)
Time frame: Up to 6-months follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Dec 2025.
- Derived from this study: PubMed 41957670Holgersen G, Nordby ES, Espeset EMS, Nordgreen T. The acceptability, adherence, and preliminary effectiveness of a digital treatment for adolescents with subthreshold eating disorders. Findings from an open feasibility trial in routine clinical care. J Eat Disord. 2026 Apr 9;14(1):115. doi: 10.1186/s40337-026-01596-9.
Related trials for Eating Disorders
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
Enrolling by invitationPhase 3
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
Binge-Eating Disorder
Recruiting
An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
Excessive Gestational Weight Gain, Pregnancy
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Tine Nordgreen, PhD principal investigator
Division of Psychiatry, Haukeland University Hospital
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Digital Treatment for Adolescents With Eating Disorders in people with Eating Disorders, run by Haukeland University Hospital at 3 sites in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Emilie Nordby, MA (55975000 ext. +47, emilie.sektnan.nordby@helse-bergen.no), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Credibility and Expectancy Scale (CEQ-1) (time frame: One week). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06306586, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.